{"id":"9974f113-1cb6-43eb-9ff6-3b07dcbba0d8","name":"Corindus Vascular Robotics","slug":"corindus","description":"Robotic vascular intervention company. Acquired by [Siemens healthineers](/companies/siemens-healthineers) for ~$1.1B (2019). Product: CorPath system — first FDA-cleared robotic-assisted vascular intervention platform. Enabled remote-controlled precision for PCI, peripheral vascular, and neurovascular procedures. $100M+ total raised before acquisition.","status":"acquired","founded":null,"hq":"USA","hqLat":39.7837304,"hqLng":-100.445882,"hqGeocodedAt":"2026-08-05T14:25:26.053Z","hqAddress":null,"hqPrecision":null,"website":"https://www.siemens-healthineers.com","fundingTotal":"100000000","type":"hardware","roles":[],"reviewStatus":"reviewed","heatIndex":75,"lifecycleState":"active","supersededByCompanyId":null,"sources":[{"url":"https://etd.ohiolink.edu/acprod/odb_etd/ws/send_file/send?accession=case1618854255867602","title":"Corindus Siemens acquisition","sourceName":"Academic source","dateAccessed":"2026-07-22"},{"url":"https://academy.siemens-healthineers.com/_/en-us/corindus-robotic-pci-introduction-to-corpath-grx-online-training/","title":"Corindus Robotic PCI - Introduction to CorPath GRX Online Training","sourceName":"Siemens Healthineers Academy"},{"url":"https://www.siemens-healthineers.com/press/releases/pr-corpath-pci-ukgm.html","title":"University Hospital Giessen performs first minimally invasive, robotic-assisted coronary intervention in Germany","sourceName":"Siemens Healthineers"}],"keyFacts":[{"label":"Product","value":"CorPath, FDA-cleared robotic vascular intervention platform"},{"label":"Acquisition","value":"Siemens Healthineers ~$1.1B (2019)"},{"label":"Total Funding","value":"$100M+ pre-acquisition"},{"label":"Status","value":"Acquired, now Siemens Healthineers Corindus"},{"label":"CorPath GRX robotic PCI","value":"Siemens Healthineers Academy identifies CorPath GRX as a robotic percutaneous coronary intervention platform developed by Corindus (CorPath GRX introduction)"},{"label":"Robotic coronary intervention","value":"Siemens Healthineers reported that University Hospital Giessen performed a minimally invasive robotic-assisted coronary intervention using CorPath GRX (Siemens Healthineers press release)"}],"aliases":["Corindus"],"collisionRisk":"low","reviewNote":null,"atsProvider":null,"atsSlug":null,"factoryLocations":null,"manufacturingCapacity":null,"orgType":null,"burnSignal":null,"litigationEvents":null,"insurancePostureDisclosed":null,"unitEconomicsDisclosed":null,"tickerSymbol":null,"stockExchange":null,"secCik":null,"revenueUsd":null,"revenueBasis":null,"revenueAsOf":null,"employeeCount":null,"employeeCountBasis":null,"employeeCountAsOf":null,"marketCapUsd":null,"marketCapAsOf":null,"marketCapSource":null,"createdAt":"2026-07-22T21:32:37.672Z","updatedAt":"2026-10-22T03:04:57.259Z","jsonLd":{"@context":"https://schema.org","@type":"Organization","@id":"https://registry.deploy.report/companies/corindus","url":"https://registry.deploy.report/companies/corindus","name":"Corindus Vascular Robotics","alternateName":["Corindus"],"description":"Robotic vascular intervention company. Acquired by [Siemens healthineers](/companies/siemens-healthineers) for ~$1.1B (2019). Product: CorPath system — first FDA-cleared robotic-assisted vascular intervention platform. Enabled remote-controlled precision for PCI, peripheral vascular, and neurovascular procedures. $100M+ total raised before acquisition.","identifier":"9974f113-1cb6-43eb-9ff6-3b07dcbba0d8","address":"USA","publisher":{"@id":"https://deploy.report/#organization"}},"framework_metadata":{"framework_schema_version":"0.1.0","verification_status":"verified","maturity_stage":null,"lifecycle_state":null,"architectural_position":{"cohort":null,"sub_cohorts":[]},"within_cohort_verified_vs_claimed_pair":null,"cap_flags":[],"verification_depth":{"sources_count":3,"primary_source_types":[]}}}